Revolution Medicines Inc (NASDAQ: RVMD) is 60.84% higher on its value in year-to-date trading and has touched a low of $15.44 and a high of $48.61 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RVMD stock was last observed hovering at around $45.98 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $46.13, the stock is 5.25% and 5.48% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.6 million and changing 0.33% at the moment leaves the stock 26.11% off its SMA200. RVMD registered 88.06% gain for a year compared to 6-month gain of 53.05%. The firm has a 50-day simple moving average (SMA 50) of $43.7278 and a 200-day simple moving average (SMA200) of $36.6761.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 8.77% loss in the last 1 month and extending the period to 3 months gives it a 22.92%, and is 5.18% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.24% over the week and 3.74% over the month.
Revolution Medicines Inc (RVMD) has around 378 employees, a market worth around $7.71B and $0.74M in sales. Profit margin for the company is -69973.99%. Distance from 52-week low is 198.77% and -5.10% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.58%).
Revolution Medicines Inc quarterly earnings per share for the current quarter are estimated at -0.89 with sales reaching $810k over the same period.The EPS is expected to grow by 12.47% this year, but quarterly earnings will post -87.00% year-over-year.
332.0 institutions hold shares in Revolution Medicines Inc (RVMD), with institutional investors hold 106.53% of the company’s shares. The shares outstanding are 164.67M, and float is at 139.20M with Short Float at 12.33%. Institutions hold 104.25% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.38 million shares valued at $558.02 million. The investor’s holdings represent 0.0087 of the RVMD Shares outstanding. As of 2024-06-30, the second largest holder is WELLINGTON MANAGEMENT GROUP LLP with 13.66 million shares valued at $530.15 million to account for 0.0083 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 13.41 million shares representing 0.0081 and valued at over $520.39 million, while FARALLON CAPITAL MANAGEMENT LLC holds 0.0059 of the shares totaling 9.76 million with a market value of $378.7 million.
Revolution Medicines Inc (RVMD) Insider Activity
The most recent transaction is an insider sale by GOLDSMITH MARK A, the company’s. SEC filings show that GOLDSMITH MARK A sold 10,000 shares of the company’s common stock on Oct 01 ’24 at a price of $44.93 per share for a total of $0.45 million. Following the sale, the insider now owns 0.3 million shares.
Still, SEC filings show that on Sep 16 ’24, Anders Jack (Chief Financial Officer) disposed off 2,244 shares at an average price of $44.19 for $99152.0. The insider now directly holds 98,932 shares of Revolution Medicines Inc (RVMD).
